Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide (Q33391770)
Jump to navigation
Jump to search
scientific article published on September 7, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide |
scientific article published on September 7, 2010 |
Statements
1 reference
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide (English)
1 reference
Patrick Y Wen
1 reference
Rakesh K Jain
1 reference
Tracy T Batchelor
1 reference
Jan Drappatz
1 reference
April F Eichler
1 reference
Scott R. Plotkin
Lei Xu
1 reference
Elizabeth R. Gerstner
Colin L. Doyle
Dan G. Duda
7 September 2010
1 reference
1 reference
103
1 reference
325-332
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference